Skip to main content
Help
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Lockups
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
Analysts
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Orzaks Ilac Ve Kimya Sanayi Ticaret Anonim Sirketi (IST:ORZAX)
Turkey
· Delayed Price · Currency is TRY
Full Chart
Watchlist
Alerts
Compare
86.45
+0.95 (1.11%)
At close: Sep 11, 2026
Overview
Financials
Statistics
History
Profile
Chart
Financials
Income Statement
Balance Sheet
Cash Flow
Ratios
KPIs
Annual
Quarterly
TTM
IST:ORZAX Financials Overview
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Revenue & Profits
TTM
Annual
Indicators
TRY
TRY
Download
Full Width
5Y
10Y
Max
Chart
Revenue
Gross Profit
Operating Income
Net Income
EPS
Fiscal Year
TTM
FY 2025
FY 2024
FY 2023
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Revenue
Revenue Growth
8,532
7,331
5,715
7,618
Revenue Growth
12.00%
28.29%
-24.98%
-
Gross Profit
Gross Profit Growth
5,633
4,743
3,707
3,556
Operating Income
Operating Income Growth
2,709
2,511
2,083
2,134
Net Income
Net Income Growth
1,158
1,053
725.25
966.41
Earnings Per Share
EPS Growth
3.77
3.43
2.36
13.64
EPS Growth
-72.35%
45.16%
-82.68%
-
Revenue by Segment
TTM
Annual
TRY
TRY
Download
Full Width
5Y
10Y
Max
Chart
Food Supplement
Consolidation Adjustments
Healthcare Products, Medical and Cosmetics
Fiscal Year
TTM
FY 2025
FY 2024
FY 2023
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Food Supplement
Food Supplement Growth
13,338
11,054
-
9,327
Consolidation Adjustments
Consolidation Adjustments Growth
-4,806
-3,723
-2,535
-3,163
Healthcare Products, Medical and Cosmetics
Healthcare Products, Medical and Cosmetics Growth
-
-
8,249
1,454
Total
Total Growth
8,532
7,331
5,715
7,618
Cash & Debt
Current
Annual
Indicators
TRY
TRY
Download
Full Width
5Y
10Y
Max
Chart
Cash & Investments
Total Debt
Net Cash
Fiscal Year
Current
FY 2025
FY 2024
FY 2023
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Cash & Investments
Cash & Investments Growth
934.71
323.96
630.74
246.48
Total Debt
Total Debt Growth
5,109
3,271
1,615
1,593
Net Cash (Debt)
Net Cash Growth
-4,174
-2,947
-984.72
-1,347
Net Cash Growth
-
-
-
-
Net Cash Per Share
Net Cash Per Share Growth
-13.60
-9.60
-3.21
-19.00
Cash Flow & CapEx
TTM
Annual
Indicators
TRY
TRY
Download
Full Width
5Y
10Y
Max
Chart
Operating Cash Flow
CapEx
Free Cash Flow
Fiscal Year
TTM
FY 2025
FY 2024
FY 2023
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Operating Cash Flow
Operating Cash Flow Growth
-392.87
-703.16
755.69
1,744
Capital Expenditures
CapEx Growth
-552.93
-499.15
-362.85
-512.5
Free Cash Flow
Free Cash Flow Growth
-945.8
-1,202
392.84
1,232
Free Cash Flow Growth
-
-
-68.11%
-
Margins
TTM
Annual
Indicators
TRY
TRY
Download
Full Width
5Y
10Y
Max
Chart
Gross Margin
Operating Margin
Pretax Margin
Profit Margin
FCF Margin
Fiscal Year
TTM
FY 2025
FY 2024
FY 2023
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Gross Margin
66.02%
64.70%
64.87%
46.68%
Operating Margin
31.75%
34.24%
36.45%
28.02%
Pretax Margin
18.84%
21.26%
17.72%
17.19%
Profit Margin
13.57%
14.36%
12.69%
12.69%
FCF Margin
-11.09%
-16.40%
6.87%
16.17%
Back to Top ↑